Search - tctmd.com

Displaying 101 - 120 of 311

Sort: Relevancy | Date

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Presentation

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

January 28, 2020

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation Cardiovascular Interventions 2019

DAPT: Hot Topics in 2019

Presenter: Dean J. Kereiakes

November 01, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Presenter: Young-Hyo Lim

October 21, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Presenter: Young-Hyo Lim

September 29, 2019

Presentation TCT 2019

Belarus Presents: Minimally Invasive Hybrid Approach to Direct Device LV Remodeling in Patient With Ischemic Cardiomyopathy

Presenter: Oleg Polonetsky

September 28, 2019

Presentation TCT 2019

PENDULUM Registry: Relationship Between Platelet Reactivity and 1-Year Ischemic and Bleeding Outcomes After PCI

Presenter: Masato Nakamura

September 28, 2019

Presentation TCT 2019

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Presenter: George Hanzel

September 27, 2019

Presentation TCT 2019

AFib Patients at High Ischemic Risk Post-PCI: Role of Triple Therapy or Potent P2Y12 Inhibition?

Presenter: Dominick Angiolillo

September 27, 2019

Debate: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients - Con: Beware of Ischemic Complications — Not Ready to Drop DAPT Yet!

Presentation TCT 2019

Con: Beware of Ischemic Complications — Not Ready to Drop DAPT Yet!

Presenter: Robert Byrne

September 27, 2019

Presentation Fellows 2019

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Presenter: Ajay Kirtane

April 12, 2019

Presentation ECHO/IMAGING 2019

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 1: Nonischemic/Noninflammatory

Presenter: John P. Bois

March 23, 2019

Presentation ECHO/IMAGING 2019

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 3: Ischemic Heart Disease

Presenter: John P. Bois

March 23, 2019

Presentation OPCI 2019

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion – When to use what

Presenter: J. Jane Cao

March 09, 2019

Presentation BIT 2019

The CHIP Imperative

Presenter: Sanjog Kalra

February 08, 2019

Presentation

Variation in Revascularization Practice, Outcomes in Asymptomatic Stable Ischemic Heart Disease

January 16, 2019

Presentation TCT Abstracts Posters 2018

Remote ischemic preconditioning improves coronary microcirculatory function with a mediator not detectable by plasma mass spectrometry

Presenter: JK Lau

September 25, 2018

Presentation TCT Abstracts Posters 2018

Effects of Pulsatile Left Ventricular Support on Mechanical Efficiency in Ischemic Cardiomyopathy

Presenter: Marcelo Barros Bastos

September 25, 2018

Presentation TCT Abstracts Posters 2018

Distribution of Non-Ischemic, “Gray Zone” and Ischemic Fractional Flow Reserve (FFR) Values in Severe Coronary lesions (>70%) in a Prospective Registry

Presenter: Shiv Agarwal

September 25, 2018

Advertisement

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

Show me the Data: Key Clinical Trials of 2019

DAPT: Hot Topics in 2019

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Belarus Presents: Minimally Invasive Hybrid Approach to Direct Device LV Remodeling in Patient With Ischemic Cardiomyopathy

PENDULUM Registry: Relationship Between Platelet Reactivity and 1-Year Ischemic and Bleeding Outcomes After PCI

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

AFib Patients at High Ischemic Risk Post-PCI: Role of Triple Therapy or Potent P2Y12 Inhibition?

Con: Beware of Ischemic Complications — Not Ready to Drop DAPT Yet!

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 1: Nonischemic/Noninflammatory

MRI/CT/Nuclear Assessment of Cardiomyopathy - Part 3: Ischemic Heart Disease

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion – When to use what

The CHIP Imperative

Variation in Revascularization Practice, Outcomes in Asymptomatic Stable Ischemic Heart Disease

Remote ischemic preconditioning improves coronary microcirculatory function with a mediator not detectable by plasma mass spectrometry

Effects of Pulsatile Left Ventricular Support on Mechanical Efficiency in Ischemic Cardiomyopathy

Distribution of Non-Ischemic, “Gray Zone” and Ischemic Fractional Flow Reserve (FFR) Values in Severe Coronary lesions (>70%) in a Prospective Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content